Stockhead on MSN
Dr Boreham’s Crucible: Paradigm takes its biggest step yet in the long walk to knee OA relief
Strong patient demand and expanding trial sites are helping Paradigm progress its long-awaited phase III knee OA study.
New research from IDC exploring the use, impact and trustworthiness of artificial intelligence (AI), has found that Irish ...
With a rate cut seen more likely, the pound fell back. Sterling was quoted at 1.3076 dollars at the time of the London ...
Introduction Medication use during pregnancy is common, and socioeconomic disparities in access may contribute to maternal ...
Background Eisenmenger syndrome (ES) is a severe and fatal complication of uncorrected congenital heart disease characterised ...
Up to 81 tests priced from ₹2,799 made available across India for baseline and ongoing tracking of GLP-1 treatment ...
The Global Customer Data Platform Market is accelerating as enterprises adopt unified customer profiles, AI-driven analytics, real-time personalization, and first-party data strategies—reflected in ...
The global healthcare quality management (QMS) market is expected to grow from USD 1.42 billion in 2025 to USD 2.51 billion ...
Kibow Biotech, a leading innovator of superior probiotic supplements for maintaining kidney health, today announced the launch of Renadyl® Advanced Multivitamin for Kidney Health. It is the first and ...
Background Percutaneous ventricular assist devices (pVAD) have been increasingly used to support haemodynamics during ...
IKS Health, a global leader in care enablement solutions supporting clinicians, staff, and patients at every step of the care ...
Structured overview of Oscar Health within the health coverage sector, examining its platform model, administrative structure, and position in a regulated market.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results